Skip to main
CYAD
CYAD logo

Celyad (CYAD)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Celyad (CYAD) Stock

About Celyad (CYAD)

Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-Oncology segment consists of all assets dev...read more
Market cap$15.91M
Today's volume
Revenue (TTM)$201.32K
Avg. daily volume4.92K
EBITDA (TTM)-$6.28M
Open
Price / earnings ratio-0.43x
Today's range
Debt / equity
52 week range$0.15 - $3.07
5 year debt / equity35.6x
Beta (LTM)1.62x
Interest coverage-52.6x
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 6, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 19, 2025, the market cap for Celyad stock is $15.92M

The current P/E ratio for Celyad stock is -0.43

The 52-week high for Celyad stock is $3.07. The current Celyad stock price $undefined is 100.00% below its 52-week high

The 52-week low for Celyad stock is $0.15. The current Celyad stock price $undefined has increased 100.00% from its 52-week low

No, the Celyad stock does not pay dividends to its shareholders

How to buy Celyad stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Celyad stock

    Navigate to the Explore page. Then, type Celyad into the search bar. When you see Celyad stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Celyad stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Celyad Stock Earnings

The value each CYAD share was expected to gain vs. the value that each CYAD share actually gained.

Celyad (CYAD) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, Celyad's earnings per share (EPS) was $0. Celyad is expected to release next earnings on 05/06/2021, with an earnings per share (EPS) estimate of $0.

Buy Celyad (CYAD) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.